Structural brain changes in Alzheimer’s disease Brain alterations in Alzheimer’s disease patients begin years before symptoms appear and a clinical diagnosis can be made. The neuroimaging team in our group has developed a technique that measures the movement of water particles in the cerebral cortex and makes it possible to detect structural changes in the … Read more
Biomarkers for the diagnosis of Alzheimer’s disease The characteristic symptoms of Alzheimer’s disease, such as progressive memory loss or other cognitive deficits and behavioral disorders, can make us suspect the diagnosis of this disease. This suspicion can be supported by the determination of biomarkers. Biomarkers measure the biological changes that occur in the brains of … Read more
Dr. Ignacio Illán-Gala has been selected as one of the “Atlantic Fellows” of the Global Brain Health Institute (GBHI) in 2019. The objective of this program, coordinated by the University of California San Francisco and Trinity College Dublin, is to promote brain health globally by training a network of future leaders in brain health. The … Read more
The Instituto de Salud Carlos III (Institute of Health Carlos III) has awarded subvention grants to four research projects submitted by the Sant Pau Memory Unit in the 2018 call for Health Research and Development Strategy in the modality of Proyectos de Investigación en Salud (Health Research Projects). This is an annual national competitive call that … Read more
Dr. María Carmona-Iragui has recently received the Doctoral Thesis Extraordinary Award in Neuroscience for her work entitled: “Sporadic cerebral amyloid angiopathy: beyond lobar intracerebral hemorrhage. Multimodal biomarker studies of atypical presentations”. Her work was co-directed by Dr. Rafael Blesa, Dr. Alberto Lleó and Dr. Juan Fortea, and deepened in the analysis of different forms of presentation … Read more
The Alzheimer – Down Unit, that comprises researchers from the Sant Pau Memory Unit of the Neurology Service at Hospital de la Santa Creu i Sant Pau and the Fundació Catalana Síndrome de Down, has published the results of a study of biomarkers in blood and cerebrospinal fluid of adults with Down syndrome in the … Read more